AHA Science (@AHAScience) header
AHA Science (@AHAScience) profile picture

AHA Science

@AHAScience

@American_Heart’s official account for meetings, science news, funding opportunities and membership. RTs/Follows not endorsements. Pump up your career, here.

 Dallas, TX
professional.heart.org/
Joined January 2009
  • Tweets13.8K
  • Following4.7K
  • Followers76.1K
In case you missed it, here are all late breaking clinical trial results from #ScientificSessions26.
A table titled "AHA Scientific Sessions 2026 — Late-Breaking Science I-VI" in Chicago, IL, from November 6-9, 2026. The table has four columns: Trial Acronym, Title, Topics of Focus, and Results. The table includes various studies related to cardiovascular topics with acronyms and brief descriptions. AHA logo is visible at the top.

ALT A table titled "AHA Scientific Sessions 2026 — Late-Breaking Science I-VI" in Chicago, IL, from November 6-9, 2026. The table has four columns: Trial Acronym, Title, Topics of Focus, and Results. The table includes various studies related to cardiovascular topics with acronyms and brief descriptions. AHA logo is visible at the top.

A table from the AHA Scientific Sessions 2026 details late-breaking science presentations. It includes columns for trial acronym, title, topics of focus, and results. The event is scheduled for November 6-9, 2026, in Chicago, IL.

ALT A table from the AHA Scientific Sessions 2026 details late-breaking science presentations. It includes columns for trial acronym, title, topics of focus, and results. The event is scheduled for November 6-9, 2026, in Chicago, IL.

3
45
127
8,126
US Veterans make up more than 5% of the US adult population. Compared with the general US population, Veterans are older, have more comorbidities, and face unique structural barriers, including high rates of rural location and less internet access. With time, the makeup of Veterans is becoming increasingly diverse in race, ethnicity, age, gender, and military exposure history. Veterans receiving care in the Veterans Administration (VA) have higher rates of obesity, diabetes, hyperlipidemia, hypertension, and sleep disorders compared to the general population. Data from the Million Veteran Program show that fewer than 5% of Veterans achieve optimal cardiovascular health based on the American Heart Association’s Life’s Essential 8 domains, which in turn has been associated with reduced life expectancy. ✍🏼 @yuanneal @AIDALMARZOOQ @wccushman @jenmartinsleeps @Lisa_Jackson_MD 📷 Meeting the cardiovascular health promotion needs of US veterans: challenges and responses. professional.heart.org/en/sc…
A journal article titled "Cardiovascular Health Promotion for US Veterans: Current State, Gaps, and Strategies: A Scientific Statement from the American Heart Association" published in Circulation. The document includes a list of authors and affiliations, followed by an abstract summarizing the statement's focus on cardiovascular health, disparities, and strategies for US veterans. The article emphasizes the importance of holistic health approaches and support from the Veterans Health Administration.

ALT A journal article titled "Cardiovascular Health Promotion for US Veterans: Current State, Gaps, and Strategies: A Scientific Statement from the American Heart Association" published in Circulation. The document includes a list of authors and affiliations, followed by an abstract summarizing the statement's focus on cardiovascular health, disparities, and strategies for US veterans. The article emphasizes the importance of holistic health approaches and support from the Veterans Health Administration.

This image is an infographic titled "Cardiovascular Health Promotion Goals (Life’s Essential 8)." It features various icons representing different health goals, such as healthy eating, physical activity, and managing blood pressure. Below, it addresses challenges in veteran populations, including service-related exposures and high rates of chronic disease. It also lists VA initiatives like rural care initiatives and comprehensive women's health care. The layout is structured in three blocks with colorful icons and text.

ALT This image is an infographic titled "Cardiovascular Health Promotion Goals (Life’s Essential 8)." It features various icons representing different health goals, such as healthy eating, physical activity, and managing blood pressure. Below, it addresses challenges in veteran populations, including service-related exposures and high rates of chronic disease. It also lists VA initiatives like rural care initiatives and comprehensive women's health care. The layout is structured in three blocks with colorful icons and text.

3
5
15
1,491
Patients with CKM syndrome often have multiple conditions requiring care from several clinicians, which can lead to fragmentation of care. Incorporating clinical input from multiple disciplines within the CKM framework and coordinating care among team members are essential components of holistic CKM care. The need for a point person is emphasized, to coordinate efforts of the CKM interdis¬ciplinary team, to facilitate implementation of evidence-based care and guideline-directed medical therapy and to support patients and clinicians. professional.heart.org/en/sc… ✍🏼 @ChiadiNdumele @HeartDocSadiya @kardiologykazi @noshreza @virani_md @biykemb @NutritionHF @mandeepbajaj65 @KatherineTuttl8 @RangaswJ @lisaVWMD @KBreathettMD @EmoryFamMed @ShoaClarke @mad_sters @jmortonmd @sripalbangalore @AnumSaeedMD
Image from AHA Science (@AHAScience)
2
6
23
1,642
AI is transforming cardiovascular care at the point of care, creating new opportunities to close the gap between scientific discovery and patient care. At #ScientificSessions26, past American Heart Association President Bob Harrington, MD, FAHA and OpenAI's Nate Gross, MD, explored how AI can help accelerate the future of medicine. 💡 @HeartBobH, @NG
2
7
18
1,356
As #ScientificSessions26 comes to a close, we celebrate the science, innovation and collaboration that continue to shape the future of cardiovascular and brain health. Now, we look ahead to a historic milestone. Join us in Boston for the 100th Scientific Sessions, Nov. 5-8, 2027. @HeartDocSadiya @bnallamo #ScientificSessions27
1
11
2
36
2,831
Replying to @AnastasiaSMihai
@AnastasiaSMihai discusses late breaking science from ATTAIN-OSA at #ScientificSessions26. 🎥
1
7
1
22
1,974
Replying to @mirvatalasnag
@mirvatalasnag discusses late breaking science from SYNCHRONIZE-CVOT at #ScientificSessions26. 🎥
2
11
1
25
2,923
SYNCHRONIZE-CVOT results presented at #ScientificSessions26 In adults with obesity and established cardiovascular or chronic kidney disease, or increased cardiovascular risk, survodutide was non-inferior to placebo for a composite of cardiovascular death, non-fatal cardiovascular events, coronary revascularization, and heart failure events, while also improving cardiometabolic markers.
This image contains a slide presentation about the SYNCHRONIZE-CVOT study. The study focuses on cardiovascular outcomes with Survodutide in adults with obesity at increased cardiovascular risk. Objectives, design, and conclusions of the study are summarized. An American Heart Association logo appears in the lower-left corner.

ALT This image contains a slide presentation about the SYNCHRONIZE-CVOT study. The study focuses on cardiovascular outcomes with Survodutide in adults with obesity at increased cardiovascular risk. Objectives, design, and conclusions of the study are summarized. An American Heart Association logo appears in the lower-left corner.

3
8
1
11
1,595
ATTAIN-OSA results presented at #ScientificSessions26 Among adults with moderate-to-severe OSA and overweight or obesity without diabetes, orforglipron significantly reduced apnea-hypopnea index compared with placebo at 52 weeks, both in participants using and not using positive airway pressure therapy.
Image from AHA Science (@AHAScience)
2
8
1
26
2,483
Replying to @DrDamluji
@DrDamluji discusses late breaking science from OCEANIC-STROKE at #ScientificSessions26. 🎥
4
18
1,739
Science shared at #ScientificSessions26 is reshaping how we think about menopause and cardiovascular health. Explore educational content today. Learn more: bit.ly/3UwC6la
Image from AHA Science (@AHAScience)
1
4
9
983
Women's health is having a major moment at #ScientificSessions26. Jennifer Ashton, MD, MS, FACOG, is helping drive important discussions around menopause, women's cardiovascular health, and the latest insights shaping care for women across every stage of life.
1
9
1
34
1,856
RACE-CARS results presented at #ScientificSessions26 Compared with usual care, the multifaceted intervention did not result in a greater percentage of patients who survived to hospital discharge with a favorable neurologic outcome.
Certainly! Here's a possible alt text description: "Slide with titled RACE-CARS: Randomized Cluster Evaluation of Cardiac ARrest Systems. It describes a study in North Carolina involving 60 counties and 22,459 patients. Objective: Evaluate emergency dispatch and community response intervention on cardiac arrest outcomes. Conclusion: The intervention showed no significant difference in survival with favorable neurological outcome compared to usual care. Includes American Heart Association logo.

ALT Certainly! Here's a possible alt text description: "Slide with titled RACE-CARS: Randomized Cluster Evaluation of Cardiac ARrest Systems. It describes a study in North Carolina involving 60 counties and 22,459 patients. Objective: Evaluate emergency dispatch and community response intervention on cardiac arrest outcomes. Conclusion: The intervention showed no significant difference in survival with favorable neurological outcome compared to usual care. Includes American Heart Association logo.

1
8
11
1,326
SUPERIOR results presented at #ScientificSessions26 Sacubitril/valsartan reduced the risk of documented atrial tachyarrhythmia recurrence at 12 months compared to valsartan in older patients with HTN undergoing catheter ablation for AF.
The image is a presentation slide from the American Heart Association. It discusses a study comparing Sacubitril/Valsartan to Valsartan for reducing atrial fibrillation in older patients with hypertension. The slide includes the objective, study design, and conclusion, stating that Sacubitril/Valsartan reduced the risk of atrial tachyarrhythmia recurrence compared to Valsartan over 12 months. The American Heart Association logo is present.

ALT The image is a presentation slide from the American Heart Association. It discusses a study comparing Sacubitril/Valsartan to Valsartan for reducing atrial fibrillation in older patients with hypertension. The slide includes the objective, study design, and conclusion, stating that Sacubitril/Valsartan reduced the risk of atrial tachyarrhythmia recurrence compared to Valsartan over 12 months. The American Heart Association logo is present.

8
2
25
2,252
Replying to @robmentz
@robmentz discusses late breaking science from Yoga-CaRe HF at #ScientificSessions26. 🎥
7
32
2,108
Replying to @GarimaVSharmaMD
@GarimaVSharmaMD discusses late breaking science from STREAM at #ScientificSessions26. 🎥
4
22
1,535
Under the leadership of Chair @Dezfulian_CCM, and Chair-Elect Ashish Panchal, MD, PhD, FAHA, #ReSS26 continues to elevate resuscitation science with innovative sessions, expert perspectives, and meaningful collaboration across disciplines. 🎥
2
15
1,313
Replying to @ycommodore
@ycommodore discusses late breaking science from REDUCE at #ScientificSessions26. 🎥
4
15
1,292
Replying to @AnastasiaSMihai
@AnastasiaSMihai discusses late breaking science from OPTIMAL-STROKE at #ScientificSessions26. 🎥
7
25
1,868
Replying to @emilyswlau
@emilyswlau discusses late breaking science from Lp(a) HORIZON at #ScientificSessions26. 🎥
1
10
1
48
2,331
Load more